–
–
The Russian Direct Investment Fund (RDIF, according to its acronym in English) celebrated the decision of the Russian government in a post on the networks, during the afternoon of this Monday.
The data is known the same day that the Argentine Government announced that the doses of Moderna will be included in the study of combined schemes carried out by the Ministry of Health in the country to supply the arrival delays of second doses of the Russian vaccine.
This is a study to authorize heterologous vaccination schedules against the coronavirus, that is, the possibility of use vaccines from different laboratories in the same immunization.
Until now, in Argentina, combinations of doses of AstraZeneca, China’s Sinopharm and Russia’s Sputnik-V, the latter is the one that presents longer delay for second applications.
Moderna’s vaccines arrived in Argentina on July 16, through a donation from the government of the United States. There are 3.5 million doses. They were received on that occasion by the Chief of Staff, Santiago Cafiero, and the Charge d’Affaires of the United States Embassy, MaryKay Carlson.
Vaccines in Argentina
AstraZeneca is one of the immunization flags raised by the Government. The active ingredient in this vaccine is manufactured in the country
In fact, a flight with more than 800 thousand doses of the AstraZeneca vaccine is scheduled to arrive in the country this Monday. With this batch, Argentina will have received a total of 41,833,930 doses, of which, just over 16 million arrived during the course of this month.
With the arrival of the flight from the United States, Argentina will have a total of 16,127,200 doses received during July: 1,141,000 from component 1 of Sputnik V and 603,000 from component 2; 2,883,200 to AstraZeneca and Oxford; 3,500,000 from Moderna; and from China, 8,000,000 from the Sinopharm laboratory.
Since the start of the immunization campaign in December 2020, almost 42 million doses.
Sinopharm’s Chinese laboratory is the one that delivered the most vaccines to the country: 14,000,000; Russia follows with Sputnik V with 11,868,830 (9,375,670 for component 1 and 2,493,160 for component 2); AstraZeneca Oxford whose active component is produced in the country, with 9,140,600 doses.
In fourth place is Moderna with the arrival of 3,500,000 doses. They total the table, 1,944,000 from AstraZeneca by the WHO COVAX mechanism and 580,000 from AstraZeneca-Covishield, produced in India.
DS
TOPICS THAT APPEAR IN THIS NOTE
–
– .
Related
